论文部分内容阅读
本文对56例原发性肾小球疾病患者,随机分为昆明山海棠(山海棠)加小剂量激素治疗组及常规剂量激素、免疫抑制剂对照组两组进行观察。结果示两组疗效相近(P>0.05),而复发及药物副作用,治疗组较对照组明显减少(P<0.05,P<0.005)。初步提示山海棠对治疗原发性肾小球疾病是一有希望的药物。
In this paper, 56 patients with primary glomerular disease were randomly divided into Begonia (Begonia hepatica) plus small dose of hormone therapy group and conventional dose hormone, immunosuppressive control group two groups were observed. The results showed that the two groups of similar efficacy (P> 0.05), while the recurrence and drug side effects, the treatment group was significantly reduced compared with the control group (P <0.05, P <0.005). Preliminary indications Begonia on the treatment of primary glomerular disease is a promising drug.